Fundraising FoxMirna Therapeutics
OTC: SYBXAustin, US · 7 known investors
Find your way into Mirna Therapeutics
Sign up to see every warm intro you have to Mirna Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mirna Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.
Founders & leadership
Board
Investors · 7
How we know: the S-1 prospectus · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$121.8M disclosed across 2 of 3 rounds · 2015–2019
▶$80MraisedJun 2019 · 1 investors · BiotechnologyRule 506(b)
- Edward MathersDirector
- Chau KhuongDirector
- Patricia HurterDirector
- Peter BarrettDirector
- Michael PowellDirector
- Aoife BrennanExecutive Officer, Director
- Nick LeschlyDirector
- Richard P. SheaDirector
- Todd ShegogExecutive Officer
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.8MraisedMay 2015 · 24 investors · PharmaceuticalsRule 506(b)
- Matthew WinklerDirector
- Michael PowellDirector
- Clay SiegallDirector
- Sinil KimExecutive Officer
- Paul LammersExecutive Officer, Director
- Jon IrvinExecutive Officer
- Larry AllevaDirector
- Corey GoodmanDirector
- Casi DeYoungExecutive Officer
- Ed MathersDirector
- Elaine JonesDirector
- Offering amount
- $45M
- Amount sold
- $41.8M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Mirna Therapeutics do?
- A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.
- Who founded Mirna Therapeutics?
- Mirna Therapeutics was founded by Matthew Winkler.
- Who are Mirna Therapeutics's investors?
- Mirna Therapeutics's investors include New Enterprise Associates (NEA), Pfizer Venture Investments, Correlation Ventures, OrbiMed, OUP (Osage University Partners), Pfizer Ventures, Sofinnova Ventures.
- How much funding has Mirna Therapeutics raised?
- Mirna Therapeutics has disclosed $121.8M raised across 2 of its 3 known rounds.
- Where is Mirna Therapeutics headquartered?
- Mirna Therapeutics is headquartered in Austin, US.